Uptown Research Institute Logo Banner

Add on Treatment – Outpatient

About the Study

This study examines the effectiveness of adding another medication to your current schizophrenia treatment to see if it improves your symptoms. Great for people seeking further reduction in their symptoms from schizophrenia. This study is sponsored by Concert Pharmaceuticals.

Length of Study: 12 weeks

Eligibility 

You may be eligible to participate in this study if you:

  • are between the ages of 18 – 55
  • have been diagnosed with schizophrenia
  • are currently taking medication to treat schizophrenia
  • have not been hospitalized for worsening of schizophrenia in the past 3 months

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed.

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 117 today. You can also fill out the contact form below.

Depression Studies Form
Please let us know any additional information here.
Sending

Share this post on Facebook

Leave Comment